Version May 2024
Local infections: Topical (0.1% to 0.5% solutions): Apply by irrigation, instillation, spray, soaks, or wet compresses. Refer to manufacturer's information for more details.
There are no dosage adjustments provided in the manufacturer’s labeling.
There are no dosage adjustments provided in the manufacturer’s labeling.
Refer to adult dosing.
There are no adverse reactions listed in the manufacturer's labeling.
Application of the powder directly to skin (must be used as a solution); systemic use or if unable to have direct contact with the infected site.
Appropriate use:
• Bladder/eye installation: Instillation of 0.2% solution, particularly into the bladder or into the eye, may cause severe discomfort. Pretreat the eye with a topical anesthetic. In the bladder, use a 0.1% concentration for the first treatment, instilling the solution to the capacity of the bladder without over-distention.
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Powder for solution, topical, as sodium:
Clorpactin® WCS-90: 2 g/bottle
No
Topical: Apply by irrigation, instillation, spray, soaks, or wet compresses, preferably thoroughly cleansing with gravity flow irrigation or with a syringe to provide copious quantities of fresh solution to remove organic wastes and debris.
May bleach fabrics or other materials if splashing or spilling occurs.
Local infections: Treatment of localized infections, particularly when resistant organisms are present; to remove necrotic debris in massive infections or from radiation necrosis; to counteract odorous discharges; as a preoperative and postoperative irrigant and for the cleansing and disinfection of fistulae, sinus tract, empyemas, and wounds.
None known.
There are no known significant interactions.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
